H.C. Wainwright analysts increased their price target on Protalix BioTherapeutics (NYSE:PLX) stock to $15.00 from the previous $10.00 while continuing to recommend a Buy rating for the company. The ...
We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback